Tumor Microenvironment and Cancer Immunology Program, National Cancer Institute designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Laboratory of Molecular Immunology, Infectious and Inflammatory Diseases Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
J Exp Med. 2021 May 3;218(5). doi: 10.1084/jem.20200971.
Regnase-1 is an emerging regulator of immune responses with essential roles in the posttranscriptional control of immune cell activation. Regnase-1 is expressed in B cells; however, its B cell-specific functions remain unknown. Here, we demonstrate that Regnase-1 prevents severe autoimmune pathology and show its essential role in maintaining B cell homeostasis. Using Cre driver mice for ablation of Regnase-1 at various stages of B cell development, we demonstrate that loss of Regnase-1 leads to aberrant B cell activation and differentiation, resulting in systemic autoimmunity and early morbidity. The basis of these findings was informed by gene expression data revealing a regulatory role for Regnase-1 in the suppression of a transcriptional program that promotes B cell activation, survival, and differentiation. Overall, our study shows that Regnase-1 exerts critical control of B cell activation, which is required for prevention of immunopathology.
Regnase-1 是一种新兴的免疫反应调节剂,在免疫细胞激活的转录后控制中具有重要作用。Regnase-1 在 B 细胞中表达;然而,其 B 细胞特异性功能仍不清楚。在这里,我们证明 Regnase-1 可预防严重的自身免疫病理,并显示其在维持 B 细胞动态平衡中的重要作用。使用 Cre 驱动小鼠在 B 细胞发育的各个阶段消融 Regnase-1,我们证明 Regnase-1 的缺失导致 B 细胞异常激活和分化,导致全身性自身免疫和早期发病。这些发现的基础是通过基因表达数据揭示的,这些数据表明 Regnase-1 在抑制促进 B 细胞激活、存活和分化的转录程序方面具有调节作用。总的来说,我们的研究表明,Regnase-1 对 B 细胞激活具有关键的控制作用,这对于预防免疫病理学是必需的。